Third Assessment Pathway for Listed Complementary Medicines
Intermediate Level – Listed Assessed Medicines Reform recommendations for complementary [...]
Intermediate Level – Listed Assessed Medicines Reform recommendations for complementary [...]
12 November 2017 will see the variation to Standard 1.4.4 [...]
The four-year transition period for the new labelling requirements (from [...]
As of 1 September 2017 the TGA’s Pharmacovigilance Inspection Program [...]
In September 2016, the Government announced that the TGA would [...]
An updated version of the Therapeutic Goods (Permissible Ingredients) Determination [...]
An update to the draft Permitted Substances List has been [...]
The opportunity to declare $0 turnover for ARTG entries became [...]
Most TGA fees and charges will increase by 1.65% (subject [...]
Declarations for annual charge exemptions are due NO LATER THAN: [...]